Encofosbuvir

艾考磷布韦

Report date: 2025/03/31 15:18:12
NME

Base Information

Drug NameEncofosbuvir
Drug Alias Name英强布韦Yiqibuvir东英贺HEC-110114
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHepatitis C virus NS5B RNA-dependent RNA polymerase inhibitors
TargetsHepatitis C virus NS5B RNA-dependent RNA polymerase
Therapy Area/IndicationsHepatitis C, ChronicHepatitis C
Global Approved IndicationsHepatitis C, Chronic
Approved Indications in ChinaHepatitis C, Chronic
Original Approved Country/TerritoryMainland China
Original Approved Date2025/03/25
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGuangdong Dongyangguang Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesSunshine Lake Pharma Co LtdYichang Hec Changjiang Pharmaceutical Co LtdGuangdong Dongyangguang Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis C, ChronicHepatitis C
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A